Identification of Novel Fusion Genes in Pediatric B-ALL Using Whole Transcriptome Sequencing
Fusion genes (FGs), serving as diagnostic, prognostic, and therapeutic markers, are key molecular aberrations in acute leukemia. They are also essential for risk stratification and measurable residual disease (MRD) monitoring. This study aimed to characterize the distribution of FGs using whole transcriptome sequencing (WTS).Materials and Methods: A total of 12 newly diagnosed treatment naive pediatric B-ALL cases from a local tertiary care hospital were enrolled in this study. Following the nucleic acids isolation procedures, the RNA sequencing was done for 12 B-ALL patients to find the fusion genes.